Supplementary Figure 4. Individual Aldosterone, PRA-S and ACE-S levels before and after placebo or eplerenone treatment in CKD patients with T2DM. (PRA-S=
angiotensin based marker for renin, ACE-S= angiotensin based marker for angiotensin- converting enzyme). For better visualization data are plotted logarithmically on the y-axis.
Placebo pre
Placebo post
1 1 0 1 0 0 1 0 0 0
Aldosterone [pmol/L]
Eplerenone pre
Eplerenone post
1 1 0 1 0 0 1 0 0 0 1 0 0 0 0
Aldosterone [pmol/L]
Placebo pre
Placebo post
1 1 0 1 0 0 1 0 0 0 1 0 0 0 0
PRA-S [pmol/L]
Eplerenone pre
Eplerenone post
1 1 0 1 0 0 1 0 0 0 1 0 0 0 0
PRA-S [pmol/L]
Placebo pre
Placebo post
0 .0 0 1 0 .0 1 0 .1 1
ACE-S [(pmol/L/pmol/L)]
Eplerenone pre
Eplerenone post
0 .0 0 1 0 .0 1 0 .1 1
ACE-S [(pmol/L/pmol/L)]